Liaison Healthcare, a global provider of secure cloud-based integration and data management services and solutions, announced today the launch of its Global CRO Integration Hub. The solution provides both pharmaceutical companies and contract research organizations (CROs) with a platform that simplifies the integration and harmonization of clinical patient and operational data across the clinical trial process.
Liaison recognizes the importance of increasing collaboration and improving interoperability for clinical trials between sponsors, CROs, providers and patients. In today's healthcare environment, pharmaceutical companies are outsourcing clinical trials to a variety of CROs. Information is constantly flowing between both entities throughout execution of the clinical trial. Given the number of electronic data capture solutions and trial designs; standardizing data is quite daunting. Adding to this complexity, the U.S. Food and Drug Administration (FDA) prefers all clinical trial information is electronically submitted in the CDISC Study Data Tabulation Model (SDTM) format, which is typically not the way information is stored natively and can vary from firm to firm.
"Pharmaceutical companies continue to increase partnerships with contract research organizations (CRO) for clinical trials as a way to speed drugs to market," said Dan Serretti, Director of Global Clinical Development Integrations at Merck. "Liaison recognizes the importance of increasing collaboration and improving interoperability for clinical trials between sponsors, CROs, providers and patients."
Liaison Healthcare identified the need for a scalable, easy-to-use solution that automates and streamlines data exchange; accurately transforming clinical trials data into a compatible format for pharmaceutical companies, CROs, Government registries and the FDA. The Global CRO Integration Hub provides cloud-based connectivity and translation support to enable interoperability throughout the clinical trial process. By implementing the Global CRO Integration Hub solution, pharmaceutical companies and CROs are able to:
"The success and timing of a clinical trial is highly dependent on the accessibility of accurate and real-time information throughout the process," said Gary Palgon, Vice President, Healthcare Solutions, Liaison Healthcare. "Liaison Healthcare¹s Global CRO Integration Hub streamlines the exchange of data so that critical information can be leveraged into actionable insight, ultimately improving speed-to-market and availability of drugs to improve patient care."
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.